News

GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval
Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...
Zenas Biopharma: A Risky Buy On Upcoming Data Readouts In IgG4, MS
Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...
StockStory.org on MSN6h
Why QuidelOrtho (QDEL) Shares Are Sliding Today
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 3.7% in the morning session after the company ...
FTSE 100 Live 28 July: Markets lifted by EU trade deal, more firms in distress
The FTSE 100 index is set for a strong start to the week, with futures pointing to a rise of about 0.5% on the back of ...
NDTV Profit on MSN19h
Q1 Results Next Week: BEL, L&T, ITC, Maruti Suzuki, Tata Steel, Mazagon Dock And Others To Declare Earnings
NTPC, Swiggy, Varun Beverages, Adani Green Energy, IndusInd Bank and Hindustan Unilever are among the 500+ Companies to ...
GlaxoSmithKline Pharmaceuticals shares fall 2.01%; among top losers on Nifty Midcap 150
With the stock's last traded price at Rs 3,081, GlaxoSmithKline Pharmaceuticals has experienced a notable decline, positioning it among the top losers on the Nifty Midcap 150 index.
China Market Update: Health Care Surges On Hengrui-GSK Deal, Market Cheers US-EU Trade Agreement
Asian equities were mostly higher overnight as Vietnam and Indonesia outperformed while Japan and India underperformed. Hong ...